OIA response: Zapril
12 March 2020
30 January 2020
[name and contact details redacted]
Dear [name redacted]
REQUEST FOR INFORMATION
Thank you for your request dated 20 January 2020, under the Official Information Act 1982 (OIA), for information relating to Zapril. You asked:
- Who manufactures Zapril?
- Is Zapril a Generic?
- If so, what is the brand name and who manufacturers the brand?
Zapril is a tradename of the generic medicine cilazapril. It is manufactured by Mylan Laboratories Limited and is supplied in New Zealand by Mylan New Zealand Ltd.
The originator brand of cilazapril was Inhibace, manufactured by F Hoffmann-La Roche Ltd in Switzerland and supplied in New Zealand by Roche Products (NZ) Ltd.
From 1 September 2019, PHARMAC changed the funded brand of cilazapril to Zapril and from 1 February 2020 Zapril will be the only fully funded brand of cilazapril.
Zapril has the same active ingredient as other brands of cilazapril and is delivered in the body the same way. This means it will have the same effect as other brands. More information about the change to Zapril can be found on PHARMAC’s website: https://www.pharmac.govt.nz/medicines/my-medicine-has-changed/cilazapril/
Product details are available on the Medsafe website as follows:
We trust that this information answers your queries. We are making our information more freely available, so we will now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.
Policy Manager, Engagement and Implementation
Last updated: 20 March 2020